Report Library Meddevicetracker

Report Library - Meddevicetracker.

Jul 01, 2022 . Report Library. Advanced Search Filters ... Meddevicetracker is owned by Informa Business Intelligence, Inc., a Massachusetts corporation with company number 042705709 ("Informa Intelligence"). Informa Intelligence's principal place of business is located at 605 Third Avenue, Floor 20, New York, New York 10158. ....

https://www.meddevicetracker.com/Reports.cfm.

Meddevicetracker.

Report Library View More . Drug Delivery: Infusion Devices. July 21, 2022. Biomedtracker / Meddevicetracker Q3... July 1, 2022. Molecular Diagnostics. ... Meddevicetracker is owned by Informa Business Intelligence, Inc., a Massachusetts corporation with company number 042705709 ("Informa Intelligence"). ....

https://www.meddevicetracker.com/.

Report Library - Biomedtracker.

Jul 08, 2022 . A UK-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase as well as exploratory mid-phase pipeline therapies for chronic myeloid leukemia..

https://www.biomedtracker.com/ReportDetail.cfm?ReportID=1664.

Frontrunner Amgen Expects US Biosimilars To ‘Shift Significantly’ ….

Jul 13, 2022 . Amgen expects a significant shift in the US biosimilars landscape as Humira rivals launch next year, Chad Pettit, the firm's executive director of marketing and global biosimilars lead, tells Generics Bulletin. The company expects to be first to market with its version of adalimumab from the end of January 2023, helping to drive long-term growth ambitions for its ....

https://generics.pharmaintelligence.informa.com/GB152019/Frontrunner-Amgen-Expects-US-Biosimilars-To-Shift-Significantly-With-Adalimumab.

Biomedtracker.

Expected Date Range Lead Company Drug Expected Catalyst; 08/09/22 Subscribers Only: Subscribers Only: Trial Data - Other: 08/09/22.

https://www.biomedtracker.com/.

How Stormy UK Politics Could Intrude On Medtech Regulatory ….

Jul 08, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://medtech.pharmaintelligence.informa.com/MT145594/How-Stormy-UK-Politics-Could-Intrude-On-Medtech-Regulatory-Readiness.

Medtech Insight | Global Medtech News :: Medtech Insight.

Aug 05, 2022 . A special podcast featuring editors Elizabeth Orr and Marion Webb from Medtech Insight, Brenda Sandburg from Pink Sheet and Malcolm Spicer from HBW Insight discussing the US Supreme Court's historic overturning of Roe v. Wade and implications for FDA-regulated sectors, from the abortion pill and OTC daily and emergency contraceptives to intrauterine ....

https://medtech.pharmaintelligence.informa.com/.

In Vivo | Life Sciences Business Strategy :: In Vivo.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://invivo.pharmaintelligence.informa.com/.

Healthcare Market Research Reports - Life Science Intelligence.

New Event! LSI Europe '22 Emerging Medtech Summit September 21-24, 2022 | The Grove Luxury Hotel | Hertfordshire | UK.

https://www.lifesciencemarketresearch.com/.

The Pace Of Cyberattacks Is Accelerating. Can Regulators Keep ….

Jun 17, 2022 . And in 2021, the Department of Health and Human Services reported data breaches from 578 health care organizations, impacting 41 million individuals. The HHS also cited the HIPAA Journal's 2020 Healthcare Data Breach Report, which says the health care industry in 2020 had the third-largest number of data breaches on record since 2009..

https://medtech.pharmaintelligence.informa.com/MT145534/The-Pace-Of-Cyberattacks-Is-Accelerating-Can-Regulators-Keep-Up.

HBW Insight | Regulatory News | Cosmetics and Dietary ….

Aug 03, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://hbw.pharmaintelligence.informa.com/.

Biomedtracker.

Meddevicetracker; Request a Demo; Login . Search All Search All; Search for Products; Search for Companies; Search for Diseases; Search for Trials; Search for Targets ... Report Library View More . Datamonitor Healthcare Oncology Dis... August 9, 2022. Datamonitor Healthcare Oncology Dis... August 8, 2022..

https://www.biomedtracker.com/index.cfm.

Germany: Leaked Pricing Measures Could Have ‘Drastic’ ….

Jul 07, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://pink.pharmaintelligence.informa.com/PS146449/Germany-Leaked-Pricing-Measures-Could-Have-Drastic-Consequences-For-Orphans.

Will 2022 Be US FDA’s Year Of ‘No’? Approval Rate For Novel ….

With 19 novel approvals and 14 complete response letters in the first half of 2022, the year is shaping up to be a turnabout from the big approval counts ....

https://pink.pharmaintelligence.informa.com/PS146464/Will-2022-Be-US-FDAs-Year-Of-No-Approval-Rate-For-Novel-Agents-Plunged-In-First-Half.

Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication.

Jul 08, 2022 . Pfizer social media announcement that it's seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA's ability to regulate pharma on social media, and the unique considerations of ....

https://pink.pharmaintelligence.informa.com/PS146457/Pfizers-Paxlovid-And-The-Murky-World-Of-Rx-Drug-Communication.

MHRA Offers Medtechs Extra Transition Time For UK Regulatory ….

Jun 27, 2022 . 26 June saw the release finally of the UK government's official response to the MHRA's 2021 consultation on its post-Brexit medical devices regulatory framework. The considered response, held up by political and internal timing issues, represents an implementation plan for reform of the system. Crucially it allows industry extra compliance time..

https://medtech.pharmaintelligence.informa.com/MT145560/MHRA-Offers-Medtechs-Extra-Transition-Time-For-UK-Regulatory-System-Compliance.

Apotex Loses Macitentan Induced Infringement Case In Canada.

Jul 14, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://generics.pharmaintelligence.informa.com/GB152023/Apotex-Loses-Macitentan-Induced-Infringement-Case-In-Canada.

Scrip | Pharmaceutical Market & Competitor Insights :: Scrip.

Aug 05, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://scrip.pharmaintelligence.informa.com/.

Global Pharma Guidance Tracker – June 2022 :: Pink Sheet.

Jul 12, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://pink.pharmaintelligence.informa.com/PS146469/Global-Pharma-Guidance-Tracker--June-2022.

Generics Bulletin | Coverage of generics, biosimilars and value ….

Aug 05, 2022 . This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183.

https://generics.pharmaintelligence.informa.com/.